Literature DB >> 12821613

More than just hype.

David Fitchett.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12821613      PMCID： PMC161606     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Ramipril use in Canada: HOPE or HYPE?

Authors:  Louise Pilote
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Authors:  J Malcolm O Arnold; Salim Yusuf; James Young; James Mathew; David Johnstone; Alvaro Avezum; Eva Lonn; Janice Pogue; Jackie Bosch
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

5.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

Authors: 
Journal:  Lancet       Date:  1993-10-02       Impact factor: 79.321

6.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Authors:  R Garg; S Yusuf
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.